Peripheral ILC2s of APL patients showed similar levels of Bcl-2 (Supplementary Fig. 1d) and increased levels of Ki-67 when compared with either peripheral ILC2s of healthy donors or BM ILC2s of APL patients (Fig. 1k). This evidence concerns the gene BCL2 and acute promyelocytic leukemia.